Company intelligence / Profile preview

Tigermed-Jyton

Beijing, Beijing, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Tigermed-Jyton is a leading Chinese contract research organization (CRO) specializing in full life cycle services for medical device development—including regulatory strategy, testing, clinical research, and commercialization. The company is recognized for its extensive partnerships with global medical device firms and robust service coverage in China and internationally, accelerated by its recent acquisition of NAMSA China and strategic global partnership with NAMSA.

Industry: Contract Research Organization

Partnerships

NAMSA (exclusive China regional partnership and global collaboration)

Beyond the preview

Go deeper on Tigermed-Jyton.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tigermed-Jyton.

Explore the full profile